Thus, most natural proteins administered as therapeutics to patients have suboptimal properties for treating the target disease. Natural proteins are not only less efficacious and less safe than ...
Natural IgMs are potential therapeutics. Clinical trials to treat multiple sclerosis with human natural IgM are underway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback